First-line single-agent panitumumab in frail elderly patients with wild-type KRAS metastatic colorectal cancer and poor prognostic factors: A phase II study of the Spanish Cooperative Group for the Treatment of Digestive Tumours
Date issued
2015Journal title
EUROPEAN JOURNAL OF CANCER
Type of content
Artigo